Paid Clinical Trials in Victoria Australia

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Victoria

Top of Directory » All Locations » Australia » Victoria


  • Hyperinsulinemic Normoglycemic Clamp for Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients

    Condition:   Postoperative Complications
    Intervention:   Other: Hyperinsulinemic Normoglycemic Clamp
    Sponsors:   McGill University Health Center;   Astellas Pharma Canada, Inc.
    Not yet recruiting - verified October 2009

  • Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

    Condition:   Psoriasis
    Intervention:   Drug: etanercept 50 mg
    Sponsors:   Innovaderm Research Inc.;   Amgen
    Recruiting - verified November 2009

  • Canadian Varicocelectomy Initiative (CVI): Effects on Male Fertility and Testicular Function of Varicocelectomy

    Conditions:   Male Infertility;   Varicoceles
    Intervention:   Procedure: Varicocelectomy
    Sponsors:   Mount Sinai Hospital, Canada;   McGill University;   Dalhousie University;   McMaster University
    Recruiting - verified November 2009

  • An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Intervention:   Drug: Dimebon
    Sponsors:   Pfizer;   Medivation, Inc.
    Recruiting - verified November 2009

  • A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy

    Conditions:   Cancer;   Cataract;   Low Bone Mineral Density;   Osteopenia;   Osteoporosis;   Prostate Cancer
    Interventions:   Biological: Denosumab;   Biological: Placebo
    Sponsor:   Amgen
    Not yet recruiting - verified November 2009

  • The Effect of an Inpatient Home-work Exercise Program on Leg Function After Stroke

    Condition:   Cerebrovascular Accident (Stroke)
    Interventions:   Behavioral: Leg Exercise Program;   Behavioral: Leg Management group
    Sponsors:   University of British Columbia;   Heart and Stroke Foundation of BC and Yukon
    Recruiting - verified November 2009

  • Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

    Condition:   Prostate Cancer
    Interventions:   Drug: abiraterone acetate plus prednisone/prednisolone;   Drug: placebo plus prednisone/prednisolone
    Sponsor:   Cougar Biotechnology, Inc.
    Recruiting - verified November 2009

  • Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

    Conditions:   Non-Hodgkin's Lymphoma;   Mantle Cell Lymphoma
    Interventions:   Drug: bendamustine and rituximab;   Drug: R-CVP or R-CHOP
    Sponsor:   Cephalon
    Recruiting - verified November 2009

  • Metabolic Abnormalities - OPT

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar I Disorder;   Metabolic Syndrome
    Interventions:   Drug: Aripiprazole;   Drug: Olanzapine;   Drug: Risperidone;   Drug: Quetiapine
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified July 2009

  • 30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event

    Conditions:   Stroke;   Transient Ischemic Attack;   Atrial Fibrillation;   Atrial Flutter
    Interventions:   Device: a 30-day ambulatory cardiac event monitor;   Device: 24-hour Holter
    Sponsor:   Sunnybrook Health Sciences Centre
    Recruiting - verified April 2009

  • 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

    Condition:   Arthritis, Rheumatoid
    Interventions:   Drug: CP-690,550;   Drug: CP-690,550;   Drug: CP-690,550;   Drug: CP-690,550;   Drug: Placebo;   Drug: CP-690,550;   Drug: Placebo;   Drug: CP-690,550
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: Dimebon;   Drug: Placebo;   Drug: Dimebon;   Drug: Placebo
    Sponsors:   Pfizer;   Medivation, Inc.
    Recruiting - verified November 2009

  • An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer

    Conditions:   Cancer;   Carcinoma;   Castrate-Resistant Prostate Cancer;   Prostate Cancer;   Tumors
    Intervention:   Drug: Denosumab
    Sponsor:   Amgen
    Recruiting - verified November 2009

  • An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis

    Condition:   Chronic Prostatitis With Chronic Pelvic Pain Syndrome
    Interventions:   Drug: Tanezumab;   Drug: Placebo
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Phase III Acute Coronary Syndrome

    Condition:   Acute Coronary Syndrome
    Interventions:   Drug: Apixaban;   Drug: Placebo
    Sponsors:   Bristol-Myers Squibb;   Pfizer;   Duke University
    Recruiting - verified October 2009

  • Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)

    Conditions:   Multiple Sclerosis;   Clinically Isolated Syndrome
    Interventions:   Drug: RNF;   Drug: RNF;   Drug: RNF;   Drug: Rebif® New Formulation (RNF)
    Sponsor:   EMD Serono
    Recruiting - verified November 2009

  • An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome.

    Conditions:   Acute Coronary Syndrome;   Myocardial Infarction;   Myocardial Ischemia;   Unstable Angina
    Intervention:   Drug: Rivaroxaban; Placebo
    Sponsors:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.;   Bayer
    Recruiting - verified November 2009

  • The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

    Conditions:   Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
    Interventions:   Drug: Darapladib;   Drug: Placebo
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

    Conditions:   Stroke;   Atrial Fibrillation;   Embolism
    Interventions:   Drug: warfarin tablets;   Drug: DU-176b tablets (high dose regimen);   Drug: DU-176b tablets (low dose regimen)
    Sponsors:   Daiichi Sankyo Inc.;   The TIMI Study Group
    Recruiting - verified November 2009

  • Treatment With Infliximab in a Medical Setting (Study P05587)

    Condition:   Crohn's Disease
    Interventions:   Biological: Infliximab;   Biological: Infliximab
    Sponsor:   Schering-Plough
    Recruiting - verified October 2009

  • One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome

    Condition:   Schizophrenia and Disorders With Psychotic Features
    Intervention:   Drug: Ziprasidone HCL (oral)
    Sponsor:   Pfizer
    Recruiting - verified October 2009

  • Follow-Up Study for Exubera

    Condition:   Diabetes Mellitus
    Interventions:   Drug: Exubera;   Other: Randomized diabetes therapy
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy

    Condition:   Ovarian Cancer
    Interventions:   Drug: EC145;   Drug: pegylated liposomal doxorubicin (PLD);   Drug: EC20;   Drug: EC20
    Sponsor:   Endocyte
    Recruiting - verified October 2009

  • Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

    Condition:   Multiple Myeloma and Plasma Cell Neoplasm
    Interventions:   Drug: bortezomib;   Drug: obatoclax mesylate
    Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
    Recruiting - verified August 2009

  • A Non-interventional Observational Registry to Assess Outcome Data in Patients Receiving Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics

    Condition:   Schizophrenia
    Intervention:   Drug: Paliperidone ER
    Sponsor:   Janssen Pharmaceutica N.V., Belgium
    Recruiting - verified November 2009

  • Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

    Condition:   Target Bleeding Site During Peripheral Vascular Surgery
    Intervention:   Biological: Human Thrombin and Human Fibrinogen
    Sponsor:   Instituto Grifols, S.A.
    Recruiting - verified October 2008

  • Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

    Condition:   Metastatic Renal Cell Cancer
    Intervention:   Drug: Everolimus
    Sponsor:   Novartis Pharmaceuticals
    Available - verified November 2009

  • CAMEO: Canadian Methotrexate and Etanercept Outcome Study

    Condition:   Rheumatoid Arthritis
    Intervention:   Biological: Etanercept
    Sponsors:   Amgen;   Wyeth
    Recruiting - verified October 2009

  • Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

    Condition:   Venous Thrombosis
    Interventions:   Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
    Sponsors:   Bristol-Myers Squibb;   Pfizer
    Recruiting - verified October 2009

  • Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia

    Condition:   Schizophrenia
    Intervention:   Drug: Quetiapine Fumarate Extended- Release
    Sponsor:   AstraZeneca
    Recruiting - verified October 2009

  • Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism

    Condition:   Venous Thrombosis
    Interventions:   Drug: Apixaban;   Drug: Placebo
    Sponsors:   Bristol-Myers Squibb;   Pfizer
    Recruiting - verified August 2009

  • Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Liquid Certolizumab pegol;   Drug: Liquid Certolizumab pegol;   Other: Placebo;   Drug: Methotrexate
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009

  • Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Eval. of the Efficacy of Ridaforolimus)

    Conditions:   Metastatic Soft-Tissue Sarcomas;   Metastatic Bone Sarcomas
    Interventions:   Drug: ridaforolimus;   Drug: Placebo
    Sponsors:   Ariad Pharmaceuticals;   Merck
    Recruiting - verified November 2009

  • Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

    Condition:   Multiple Myeloma
    Intervention:   Drug: carfilzomib
    Sponsor:   Proteolix
    Recruiting - verified July 2008

  • Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

    Conditions:   Thrombocytopenia;   Hepatitis C
    Intervention:   Drug: eltrombopag
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients With Acute Coronary Syndrome (TRA•CER) (Study P04736AM1)

    Conditions:   Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction
    Interventions:   Drug: SCH 530348;   Drug: Placebo
    Sponsors:   Schering-Plough;   Duke University
    Recruiting - verified October 2009

  • A 5-Year Registry Study of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

    Condition:   Crohn's Disease
    Intervention:   Biological: adalimumab
    Sponsor:   Abbott
    Recruiting - verified November 2009

  • A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014179)

    Condition:   Ulcerative Colitis
    Interventions:   Biological: Golimumab, placebo;   Biological: golimumab, placebo;   Biological: Placebo
    Sponsors:   Centocor, Inc.;   Schering-Plough
    Recruiting - verified November 2009

  • A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure

    Condition:   Heart Decompensation
    Interventions:   Drug: Placebo;   Drug: Nesiritide
    Sponsor:   Scios, Inc.
    Recruiting - verified November 2009

  • Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis

    Condition:   Arthritis, Rheumatoid
    Interventions:   Drug: CP-690,550;   Drug: CP-690,550
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

    Conditions:   Atrial Fibrillation;   Atrial Flutter
    Interventions:   Drug: warfarin;   Drug: apixaban
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified October 2009

  • Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

    Condition:   Breast Cancer
    Interventions:   Biological: bevacizumab;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: conventional surgery
    Sponsors:   National Surgical Adjuvant Breast and Bowel Project (NSABP);   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • An Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis.

    Condition:   Interstitial Cystitis
    Intervention:   Drug: pentosan polysulfate sodium
    Sponsor:   McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
    Recruiting - verified November 2009

  • Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Drug: letrozole;   Other: placebo
    Sponsors:   National Surgical Adjuvant Breast and Bowel Project (NSABP);   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

    Conditions:   Arthritis, Rheumatoid;   Osteoarthritis
    Interventions:   Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
    Sponsors:   Pfizer;   The Cleveland Clinic
    Recruiting - verified November 2009

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer

    Condition:   Prostate Cancer
    Interventions:   Radiation: 3-dimensional conformal radiation therapy;   Radiation: hypofractionated radiation therapy;   Radiation: intensity-modulated radiation therapy
    Sponsors:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

    Condition:   Lung Cancer
    Interventions:   Biological: bevacizumab;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: pemetrexed disodium;   Drug: vinorelbine ditartrate
    Sponsors:   Eastern Cooperative Oncology Group;   National Cancer Institute (NCI);   Southwest Oncology Group;   Cancer and Leukemia Group B;   NCIC Clinical Trials Group;   North Central Cancer Treatment Group
    Recruiting - verified November 2009

  • Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

    Condition:   Breast Cancer
    Interventions:   Drug: anastrozole;   Drug: chemotherapy;   Drug: exemestane;   Drug: letrozole;   Drug: tamoxifen citrate
    Sponsors:   Eastern Cooperative Oncology Group;   National Cancer Institute (NCI);   Southwest Oncology Group;   Cancer and Leukemia Group B;   American College of Surgeons;   North Central Cancer Treatment Group;   NCIC Clinical Trials Group;   National Surgical Adjuvant Breast and Bowel Project (NSABP)
    Recruiting - verified November 2009

  • Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

    Condition:   Breast Cancer
    Intervention:   Radiation: radiation therapy
    Sponsors:   National Surgical Adjuvant Breast and Bowel Project (NSABP);   National Cancer Institute (NCI);   Radiation Therapy Oncology Group;   Southwest Oncology Group
    Recruiting - verified November 2009

  • Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Other: immunohistochemistry staining method;   Procedure: conventional surgery
    Sponsors:   National Surgical Adjuvant Breast and Bowel Project (NSABP);   National Cancer Institute (NCI)
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials